文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛心脑血管急症

严重呼吸衰竭、体外膜氧合与颅内出血

Severe Respiratory Failure, Extracorporeal Membrane Oxygenation, and Intracranial Hemorrhage.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论严重呼吸衰竭患者中,颅内出血患病率在ECMO支持者为16.4%、常规通气者为7.6%,但ECMO并非独立危险因素,且出血者6个月生存率与无出血者无显著差异,92%神经功能良好。

该单中心回顾性观察队列纳入2011年12月至2016年2月转至区域严重呼吸衰竭中心的342例患者(250例接受体外支持、92例常规通气),常规行入院脑影像。ECMO患者颅内出血患病率16.4%,常规通气患者7.6%(p=0.04)。多因素分析显示机械通气时长(OR 1.13,95%CI 1.03-1.23,p=0.011)和入院纤维蛋白原(OR 0.73,95%CI 0.57-0.91,p=0.009)与颅内出血独立相关,ECMO暴露不是独立危险因素(OR 3.29,95%CI 0.96-15.99,p=0.088)。接受静脉-静脉ECMO者中,有与无颅内出血的6个月生存率无显著差异(68.3% vs 76.0%,p=0.350),92%存活者神经功能良好。

要点

  • 严重呼吸衰竭患者中颅内出血患病率:ECMO支持者16.4% vs 常规通气者7.6%(p=0.04),但ECMO不是独立危险因素(OR 3.29,95%CI 0.96-15.99,p=0.088)。
  • 机械通气时长每增加1天,颅内出血风险独立升高(OR 1.13,95%CI 1.03-1.23,p=0.011);入院纤维蛋白原每升高1 g/L,风险独立降低(OR 0.73,95%CI 0.57-0.91,p=0.009)。
  • 静脉-静脉ECMO患者中,发生颅内出血者6个月生存率68.3%,无出血者76.0%,差异无统计学意义(p=0.350)。
  • 存活者中92%神经功能良好。
  • 该中心常规对转入的严重呼吸衰竭患者行入院脑影像,颅内出血患病率高于既往报道。

适用人群与场景

  • 2011年12月至2016年2月转入区域严重呼吸衰竭中心(大学教学医院)的患者,共342例,其中250例接受体外膜氧合支持、92例接受常规通气。

研究设计与关键结果

  • 单中心、回顾性、观察性队列研究,纳入342例严重呼吸衰竭患者,其中250例接受体外膜氧合支持、92例接受常规通气。
  • 颅内出血患病率:体外膜氧合患者16.4%,常规通气患者7.6%(p=0.04)。
  • 多因素分析显示颅内出血的独立相关因素为机械通气时长(天)(OR 1.13,95%CI 1.03-1.23,p=0.011)和入院纤维蛋白原(g/L)(OR 0.73,95%CI 0.57-0.91,p=0.009);体外膜氧合不是独立危险因素(OR 3.29,95%CI 0.96-15.99,p=0.088)。
  • 接受静脉-静脉体外膜氧合的患者中,有颅内出血与无颅内出血者的6个月生存率分别为68.3%与76.0%,差异无统计学意义(p=0.350)。
  • 存活者中92%神经功能良好。

证据类型、等级与局限

  • 证据类型:单中心、回顾性、观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,颅内出血是严重呼吸衰竭患者中较常见的并发症,但体外膜氧合暴露本身并非独立危险因素,机械通气时长和入院纤维蛋白原与颅内出血独立相关。
  • 作者认为,发生颅内出血的静脉-静脉体外膜氧合患者仍可有较高的神经功能完好存活率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: For patients supported with veno-venous extracorporeal membrane oxygenation, the occurrence of intracranial hemorrhage is associated with a high mortality. It is unclear whether intracranial hemorrhage is a consequence of the extracorporeal intervention or of the underlying severe respiratory pathology. In a cohort of patients transferred to a regional severe respiratory failure center that routinely employs admission brain imaging, we sought 1) the prevalence of intracranial hemorrhage; 2) survival and neurologic outcomes; and 3) factors associated with intracranial hemorrhage.

DESIGN: A single-center, retrospective, observational cohort study.

SETTING: Tertiary referral severe respiratory failure center, university teaching hospital.

PATIENTS: Patients admitted between December 2011 and February 2016.

MEASUREMENTS AND MAIN RESULTS: Three hundred forty-two patients were identified: 250 managed with extracorporeal support and 92 managed using conventional ventilation. The prevalence of intracranial hemorrhage was 16.4% in extracorporeal membrane oxygenation patients and 7.6% in conventionally managed patients (p = 0.04). Multivariate analysis revealed factors independently associated with intracranial hemorrhage to be duration of ventilation (d) (odds ratio, 1.13 [95% CI, 1.03-1.23]; p = 0.011) and admission fibrinogen (g/L) (odds ratio, 0.73 [0.57-0.91]; p = 0.009); extracorporeal membrane oxygenation was not an independent risk factor (odds ratio, 3.29 [0.96-15.99]; p = 0.088). In patients who received veno-venous extracorporeal membrane oxygenation, there was no significant difference in 6-month survival between patients with and without intracranial hemorrhage (68.3% vs 76.0%; p = 0.350). Good neurologic function was observed in 92%.

CONCLUSIONS: We report a higher prevalence of intracranial hemorrhage than has previously been described with high level of neurologically intact survival. Duration of mechanical ventilation and admission fibrinogen, but not exposure to extracorporeal support, are independently associated with intracranial hemorrhage.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lockie CJA, Gillon SA, Barrett NA, et al. Severe Respiratory Failure, Extracorporeal Membrane Oxygenation, and Intracranial Hemorrhage. Crit Care Med. 2017. PMID: 28727576. doi:10.1097/CCM.0000000000002579

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。